|

Tebentafusp Clinical Trials

8 actively recruiting trials across 6 locations

Also known as: Kimmtrak, Tebentafusp-tebn

Other2 trials

Adjuvant Tebentafusp in High Risk Ocular Melanoma
Phase 3
Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
Phase 2

Birmingham, Alabama1 trial

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

University of Alabama

Phase 1

Phoenix, Arizona1 trial

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Mayo Clinic Arizona

Phase 3

Los Angeles, California1 trial

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

University of Southern California - Norris Cancer Center

Phase 2

Aurora, Colorado1 trial

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

University of Colorado Cancer Center

Phase 2

Miami, Florida1 trial

Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma

University of Miami

Phase 2

Tampa, Florida1 trial

Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma

Moffitt Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.